Finance

Lists
SOLV:NYSE
Solventum Corp
87,29 USD
+1,02%
(+0,88) 1D
87,29 USD
0,00% (0,00)
After hours
Closed: 9-окт., 16:00:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SOLV...
Open
86,66 USD
High
88,23 USD
Low
86,66 USD
Mkt. cap
14,86 млд
Avg. vol.
889,06 миң
Volume
1,06 млн
P/E ratio
10,67
52-wk high
94,16 USD
52-wk low
62,38 USD
EPS
8,18 USD
Shares outstanding
170,22 млн
No. of employees
21 миң
Open
86,66 USD
High
88,23 USD
Low
86,66 USD
Mkt. cap
14,86 млд
Avg. vol.
889,06 миң
Volume
1,06 млн
P/E ratio
10,67
52-wk high
94,16 USD
52-wk low
62,38 USD
EPS
8,18 USD
Shares outstanding
170,22 млн
No. of employees
21 миң
News stories
From web sources and news partners
Profile
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024. Wikipedia
About Solventum Corp
CEOBryan C. Hanson
Employees20,6 миң
Founded2023
HeadquartersСейнт Пол, Миннесота, Америка Кошмо Штаттары
SectorMedical device
Analyst ratings
Based on 10 analysts giving stock ratings to SOLV in the past 3 months
Buy
Buy
7
Hold
3
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for SOLV in the last 3 months.
Highest
Current 87,29 USD
113,00 USD (+29,45%)
Average
98,50 USD (+12,84%)
Lowest
84,00 USD (-3,77%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rick Wise
Stifel Nicolaus
Buy
Maintained
100,00 USD
+14,6%
09/18/2026
Jason Bednar
Piper Sandler
Buy
Reiterated
105,00 USD
+20,3%
09/15/2026
Ryan Zimmerman
BTIG
Buy
Reiterated
95,00 USD
+8,8%
09/14/2026
Patrick Wood
UBS
Buy
Reiterated
101,00 USD
+15,7%
08/20/2026
Vik Chopra
BMO Capital
Hold
Maintained
84,00 USD
-3,8%
08/17/2026
Travis Steed
Bank of America Securities
Hold
Maintained
95,00 USD
+8,8%
08/11/2026
Nathan Treybeck
Wells Fargo
Hold
Maintained
89,00 USD
+2%
08/06/2026
Michael Piccolo
Wedbush
Buy
Reiterated
101,00 USD
+15,7%
08/06/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
113,00 USD
+29,5%
08/06/2026
Brett Fishbin
KeyBanc
Buy
Maintained
102,00 USD
+16,9%
08/06/2026
Kevin Caliendo
UBS
Buy
Upgraded
95,00 USD
+8,8%
07/28/2026
Unknown Analyst
BMO Capital
Hold
Initiated
81,00 USD
-7,2%
07/09/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
70,00 USD
-19,8%
05/22/2026
David Roman
Goldman Sachs
Sell
Maintained
66,00 USD
-24,4%
05/05/2026
Mark Strouse
J.P. Morgan
Buy
Initiated
-
-
04/06/2026
Unknown Analyst
Rothschild & Co Redburn
Sell
Initiated
60,00 USD
-31,3%
03/24/2026
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
2,55 USD / 1,91 USD
+33,78%beat
Revenue / Est. (USD)
2,21 млд / 2,16 млд
+2,47%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,10 млд
2,00 млд
2,01 млд
2,21 млд
Cost of goods sold
963,00 млн
971,00 млн
910,00 млн
914,00 млн
Cost of revenue
963,00 млн
971,00 млн
910,00 млн
914,00 млн
Research and development expenses
183,00 млн
168,00 млн
186,00 млн
178,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
786,00 млн
719,00 млн
799,00 млн
901,00 млн
Operating expense
969,00 млн
887,00 млн
985,00 млн
1,08 млд
Total operating expenses
1,93 млд
1,86 млд
1,90 млд
1,99 млд
Operating income
164,00 млн
140,00 млн
112,00 млн
216,00 млн
Other non operating income
5,00 млн
-4,00 млн
7,00 млн
-3,00 млн
EBT including unusual items
1,51 млд
58,00 млн
16,00 млн
107,00 млн
EBT excluding unusual items
80,00 млн
85,00 млн
57,00 млн
149,00 млн
Income tax expense
248,00 млн
-5,00 млн
3,00 млн
15,00 млн
Effective tax rate
16,38%
-8,62%
18,75%
14,02%
Other operating expenses
-
-
-
-
Net income
1,27 млд
63,00 млн
13,00 млн
92,00 млн
Net profit margin
60,40%
3,15%
0,65%
4,16%
Earnings per share
1,50
1,57
1,48
2,55
Interest and investment income
-
-
-
-
Interest expense
-89,00 млн
-51,00 млн
-62,00 млн
-64,00 млн
Net interest expenses
-89,00 млн
-51,00 млн
-62,00 млн
-64,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
285,00 млн
257,00 млн
247,00 млн
349,00 млн
Gain or loss from assets sale
-1,52 млд
-31,00 млн
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору